ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

ClinicalTrials.gov ID: NCT05468489

Public ClinicalTrials.gov record NCT05468489. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 7:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label Study of Serplulimab Plus Chemotherapy (Carboplatin-Etoposide) in Comparison With Atezolizumab Plus Chemotherapy in Previously Untreated US Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) (ASTRIDE)

Study identification

NCT ID
NCT05468489
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shanghai Henlius Biotech
Industry
Enrollment
200 participants

Conditions and interventions

Interventions

  • Atezolizumab + chemotherapy (carboplatin-etoposide) Drug
  • Serplulimab + chemotherapy (carboplatin-etoposide) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 17, 2022
Primary completion
Feb 27, 2026
Completion
Dec 30, 2027
Last update posted
Oct 20, 2025

2022 – 2027

United States locations

U.S. sites
67
U.S. states
30
U.S. cities
64
Facility City State ZIP Site status
Alabama Oncology Birmingham Alabama 35223
City of Hope - Phoenix Goodyear Arizona 85338
Arizona Clinical Research Center (ACRC) Tucson Arizona 85715
Highlands Oncology Group Springdale Arkansas 72762
Compassionate Care Research Group Fountain Valley California 92708
Providence Medical Foundation Fullerton California 92835
Los Angeles Cancer Network Glendale California 91204
OPN - Oncology Physician Network Los Alamitos California 90720
Kaiser Permanente Research (Southern California) Los Angeles California 90034
UC Davis Sacramento California 95817
UCHealth Memorial Hospital North Colorado Springs Colorado 80920
Banner MD Anderson Cancer Center (BMDACC) Greeley Colorado 80631
MD Anderson- North Colorado Medical Center Greeley Colorado 80631
Advanced Cancer Treatment Centers Brooksville Florida 34613
Cancer Specialists North Florida Jacksonville Florida 32256
Mount Sinai Comprehensive Cancer Center Miami Florida 33140
Florida Cancer Affiliates- (Ocala Oncology - Main) Ocala Florida 34473
Mid Florida Hematology and Oncology Center Orange City Florida 32763
BRCR Global Plantation Florida 33322
Napa Research Pompano Beach Florida 33064
Advanced Research Tamarac Florida 33321
City of Hope- Chicago Chicago Illinois 60099
Cancer Center of Decatur Decatur Illinois 62526
Accellacare of Duly Tinley Park Illinois 60487
Northwest Cancer Centers Dyer Indiana 46311
Cancer Center of Kansas Wichita Kansas 67214
Baptist Health Lexington Lexington Kentucky 40503
Pikeville Hospital Pikeville Kentucky 41501
CHRISTUS St. Frances Cabrini Cancer Center Alexandria Louisiana 71301
Pontchartrain Cancer Center Hammond Louisiana 70433
Lahey Hospital & Medical Center Burlington Massachusetts 01805
Henry Ford Health Providence Southfield Hospital Southfield Michigan 48075
Health Partners Cancer Center at Regions Hospital Saint Paul Minnesota 55101
Hattiesburg Clinic Hematology/Oncology Hattiesburg Mississippi 39401
North Mississippi Medical Center Hematology and Oncology Clinic Tupelo Mississippi 38801
MidAmerica Division Inc., c/o Research Medical Center Kansas City Missouri 64132
Lake Regional Osage Beach Missouri 65065
St. Vincent Frontier Cancer Center Billings Montana 59102
University of Nebraska Medical Center Omaha Nebraska 68106
Renown Health Reno Nevada 89502
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
Regional Cancer Care Associates LLC RCCA Freehold New Jersey 03756
Jersey Shore University Medical Center Neptune City New Jersey 07753
Elmhurst (BRANY site) Elmhurst New York 11373
Northwell Health Lake Success New York 11042
Stony Brook Cancer Center Stony Brook New York 11794
Great Lakes Cancer Care (Kaleida Health) Williamsville New York 14221
Summa Health Akron Ohio 44304
Cleveland Clinic Mercy Hospital Canton Ohio 44708
Aultman Cancer Center Canton Ohio 44710
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Tricounty Hematology and Oncology Associates Massillon Ohio 44646
CharterCARE (Roger Williams) Providence Rhode Island 02908
Monument Health Rapid City South Dakota 57701
CHRISTUS Institute for Innovation & Advanced Clinical Care Corpus Christi Texas 78404
DHR Research Edinburg Texas 78539
Millennium Research and Clinical Development Houston Texas 77090
Lumi Research Kingwood Texas 77339
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410
The University of Texas Health Science Center at Tyler/HOPE Cancer Center Tyler Texas 75701
Utah Cancer Specialists Salt Lake City Utah 84106
Huntsman Cancer Institute Salt Lake City Utah 84112
American Oncology Network Vista Oncology Division Olympia Washington 98502
Northwest Medical Specialties, PLLC Tacoma Washington 98405
West Virginia University Cancer Institute Morgantown West Virginia 26505
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53792
Froedtert Hospital- Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05468489, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05468489 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →